Immunogenicity 14709
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SENP5
Transcript ID
NM_152699
HLA INFO
A*01:01
TCR INFO
No TCR info found!
Full length protein sequence (755 aa)
MKKQR
1
KILWR
6
KGIHL
11
AFSEK
16
WNTGF
21
GGFKK
26
FYFHQ
31
HLCIL
36
KAKLG
41
RPVTW
46
NRQLR
51
HFQGR
56
KKALQ
61
IQKTW
66
IKDEP
71
LCAKT
76
KFNVA
81
TQNVS
86
TLSSK
91
VKRKD
96
AKHFI
101
SSSKT
106
LLRLQ
111
AEKLL
116
SSAKN
121
SDHEY
126
CREKN
131
LLKAV
136
TDFPS
141
NSALG
146
QANGH
151
RPRTD
156
PQPSD
161
FPMKF
166
NGESQ
171
SPGES
176
GTIVV
181
TLNNH
186
KRKGF
191
CYGCC
196
QGPEH
201
HRNGG
206
PLIPK
211
KFQLN
216
QHRRI
221
KLSPL
226
MMYEK
231
LSMIR
236
FRYRI
241
LRSQH
246
FRTKS
251
KVCKL
256
RKAQR
261
SWVQK
266
VTGDH
271
QETRR
276
ENGEG
281
GSCSP
286
FPSPE
291
PKDPS
296
CRHQP
301
YFPDM
306
DSSAV
311
VKGTN
316
SHVPD
321
CHTKG
326
SSFLG
331
KELSL
336
DEAFP
341
DQQNG
346
SATNA
351
WDQSS
356
CSSPK
361
WECTE
366
LIHDI
371
PLPEH
376
RSNTM
381
FISET
386
EREIM
391
TLGQE
396
NQTSS
401
VSDDR
406
VKLSV
411
SGADT
416
SVSSV
421
DGPVS
426
QKAVQ
431
NENSY
436
QMEED
441
GSLKQ
446
SILSS
451
ELLDH
456
PYCKS
461
PLEAP
466
LVCSG
471
LKLEN
476
QVGGG
481
KNSQK
486
ASPVD
491
DEQLS
496
VCLSG
501
FLDEV
506
MKKYG
511
SLVPL
516
SEKEV
521
LGRLK
526
DVFNE
531
DFSNR
536
KPFIN
541
REITN
546
YRARH
551
QKCNF
556
RIFYN
561
KHMLD
566
MDDLA
571
TLDGQ
576
NWLND
581
QVINM
586
YGELI
591
MDAVP
596
DKVHF
601
FNSFF
606
HRQLV
611
TKGYN
616
GVKRW
621
TKKVD
626
LFKKS
631
LLLIP
636
IHLEV
641
HWSLI
646
TVTLS
651
NRIIS
656
FYDSQ
661
GIHFK
666
FCVEN
671
IRKYL
676
LTEAR
681
EKNRP
686
EFLQG
691
WQTAV
696
TKCIP
701
QQKND
706
SDCGV
711
FVLQY
716
CKCLA
721
LEQPF
726
QFSQE
731
DMPRV
736
RKRIY
741
KELCE
746
CRLMD
751
Mutation Information
DNA mutation:
None
Peptide Range:
491 ~ 515
Mut AA position:
503 (13 in Wild Type peptide)
Alignment
Wild Type:
"ASPVDDEQLSVCLSGFLDEVMKKYG
||||||||||||.||||||||||||
Mutant:
ASPVDDEQLSVCFSGFLDEVMKKYG"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) SENP5
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay